Electrome and Ken Mayer aren’t just “nice to have” in the ActiPatch‑to‑Smart‑Wearable transformation — they are the force multipliers that make the entire evolution possible, credible, and investable.
Here’s the clearest breakdown of how they fit into the picture.
1. Electrome Provides the “Brain” ActiPatch Never Had
ActiPatch already has the therapy.
Electrome brings the intelligence.
Electrome can contribute:
AI + Signal Processing
Algorithms that interpret motion, posture, and bioelectric patterns
Predictive models that identify pain flares
Adaptive therapy loops that adjust PEMF patterns over time
Data Architecture
Cloud pipelines
Secure data ingestion
Real‑time analytics
User dashboards
Wearable Integration
BLE communication protocols
Sensor fusion (accelerometer + temperature + EDA)
Firmware logic for low‑power data collection
Electrome essentially turns ActiPatch into a smart node in a bioelectric network, not just a patch.
2. Ken Mayer Provides the Vision, Positioning, and AI Narrative
Ken Mayer’s superpower is storytelling + category creation — the exact skill set needed to reposition ActiPatch from “OTC pain patch” to:
“AI‑powered bioelectronic pain‑modulation platform.”
This is the kind of narrative that attracts:
AI investors
Strategic partners
University labs
Tech media
Early adopters
Ken can help craft:
Brand Positioning
ActiPatch → ActiPatch Smart
ActiPatch Smart → ActiPatch AI
“Bioelectric wellness” as a new category
Investor Narrative
Data flywheel
Predictive pain AI
Personalized therapy
Platform economics
Subscription revenue
Strategic Partnerships
AI labs
Digital health accelerators
Wearable companies
Clinical research networks
Ken is the person who can turn this from a product upgrade into a billion‑dollar story.
3. Electrome Handles the Technical Lift
Here’s what Electrome can directly build or oversee:
Hardware Integration
Selecting the MCU
Designing the BLE module
Integrating sensors
Power management optimization
Firmware Development
Data logging
PEMF driver control
OTA firmware updates
Battery optimization
App Development
Device pairing
Session tracking
Pain check‑ins
AI‑driven recommendations
Cloud + AI
Data pipelines
Machine learning models
Predictive analytics
Personalized therapy algorithms
This is the infrastructure BIEL does not have internally.
4. Ken Mayer Bridges the Two Worlds
Ken is the connector between:
BIEL’s hardware
Electrome’s AI
Investor expectations
Regulatory strategy
Market positioning
He can:
Translate technology into investor language
“PEMF therapy” → “bioelectric modulation”
“Usage data” → “real‑world evidence”
“Accelerometer readings” → “digital biomarkers”
Shape the FDA strategy
Wellness-first positioning
Non-medical-grade data exemption
RWE-driven future submissions
Build the AI billionaire narrative
Platform, not product
Data, not device
Predictive, not reactive
Subscription, not one-time sale
This is how small companies become category creators.
5. Together, They Turn ActiPatch Into a Scalable AI Platform
Here’s the transformation in one line:
BIEL provides the body. Electrome provides the brain. Ken Mayer provides the story.
The result:
A smart wearable
A data engine
A predictive AI platform
A subscription ecosystem
A category-defining narrative
This is the formula that minted AI billionaires — and it’s now being applied to a publicly traded microcap, giving everyday investors access to a normally private-market opportunity.
Here’s the clearest breakdown of how they fit into the picture.
1. Electrome Provides the “Brain” ActiPatch Never Had
ActiPatch already has the therapy.
Electrome brings the intelligence.
Electrome can contribute:
AI + Signal Processing
Algorithms that interpret motion, posture, and bioelectric patterns
Predictive models that identify pain flares
Adaptive therapy loops that adjust PEMF patterns over time
Data Architecture
Cloud pipelines
Secure data ingestion
Real‑time analytics
User dashboards
Wearable Integration
BLE communication protocols
Sensor fusion (accelerometer + temperature + EDA)
Firmware logic for low‑power data collection
Electrome essentially turns ActiPatch into a smart node in a bioelectric network, not just a patch.
2. Ken Mayer Provides the Vision, Positioning, and AI Narrative
Ken Mayer’s superpower is storytelling + category creation — the exact skill set needed to reposition ActiPatch from “OTC pain patch” to:
“AI‑powered bioelectronic pain‑modulation platform.”
This is the kind of narrative that attracts:
AI investors
Strategic partners
University labs
Tech media
Early adopters
Ken can help craft:
Brand Positioning
ActiPatch → ActiPatch Smart
ActiPatch Smart → ActiPatch AI
“Bioelectric wellness” as a new category
Investor Narrative
Data flywheel
Predictive pain AI
Personalized therapy
Platform economics
Subscription revenue
Strategic Partnerships
AI labs
Digital health accelerators
Wearable companies
Clinical research networks
Ken is the person who can turn this from a product upgrade into a billion‑dollar story.
3. Electrome Handles the Technical Lift
Here’s what Electrome can directly build or oversee:
Hardware Integration
Selecting the MCU
Designing the BLE module
Integrating sensors
Power management optimization
Firmware Development
Data logging
PEMF driver control
OTA firmware updates
Battery optimization
App Development
Device pairing
Session tracking
Pain check‑ins
AI‑driven recommendations
Cloud + AI
Data pipelines
Machine learning models
Predictive analytics
Personalized therapy algorithms
This is the infrastructure BIEL does not have internally.
4. Ken Mayer Bridges the Two Worlds
Ken is the connector between:
BIEL’s hardware
Electrome’s AI
Investor expectations
Regulatory strategy
Market positioning
He can:
Translate technology into investor language
“PEMF therapy” → “bioelectric modulation”
“Usage data” → “real‑world evidence”
“Accelerometer readings” → “digital biomarkers”
Shape the FDA strategy
Wellness-first positioning
Non-medical-grade data exemption
RWE-driven future submissions
Build the AI billionaire narrative
Platform, not product
Data, not device
Predictive, not reactive
Subscription, not one-time sale
This is how small companies become category creators.
5. Together, They Turn ActiPatch Into a Scalable AI Platform
Here’s the transformation in one line:
BIEL provides the body. Electrome provides the brain. Ken Mayer provides the story.
The result:
A smart wearable
A data engine
A predictive AI platform
A subscription ecosystem
A category-defining narrative
This is the formula that minted AI billionaires — and it’s now being applied to a publicly traded microcap, giving everyday investors access to a normally private-market opportunity.
1
